Timeline

Voting rights breakdown

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

• Omega Funds IV Limited10.61%
• Ares Life Sciences GP Ltd10.61%

Notice details

Beneficial owner

Omega Funds IV Limited

Santhera Pharmaceuticals (SIX: SANN) was informed by Ares Life Sciences GP Ltd, 13 Broad Street, St Helier, Jersey, Channel Island, that Omega Funds IV Limited acting on behalf of Ares Life Sciences GP Ltd, 13 Broad Street, St Helier, Jersey, Channel Island has subscribed 370,082 new registered shares of Santhera Pharmaceuticals Holding AG, representing 10.61% of the voting rights of the shares registered in the Commercial Register. Ares Life Sciences GP Ltd is held by the beneficial owners referred to below through Kedge Capital Holdings (Jersey) Limited, 13 Broad Street, St Helier, Jersey, Channel Islands. Omega Funds IV Limited is held by the beneficial owners set forth below through the Landmark Limited Partnership, a limited partnership having its registered office at 13 Broad Street, St Helier, Jersey, Channel Island. Beneficial owners are Ernesto Bertarelli, Donata Bertarelli Späth and Maria-Iris Bertrarelli, all in 3780 Gstaad, Switzerland. Contact person for this disclosure is Jacques Iffland at Lenz & Staehelin.